|Articles|March 24, 2020

Elligo Joins Efforts To Expand COVID-19 Risk Screening, Testing

Elligo Health Research, a healthcare-enabling research organization, is working with Verily to support the Project Baseline COVID-19 Program. The program is a collaboration with the California Governor’s office, federal, state and local public health authorities, to expand COVID-19 risk screening and testing. Elligo is one of the few companies to project-manage and staff drive-by COVID-19 test sites with three initial sample-collection sites that launched Monday, March 16 in San Mateo County and Santa Clara County. Additional locations are expected in the coming weeks.

Elligo is also providing a full spectrum of solutions to help manage COVID-19 testing efforts on-site and off-site, including access to staff and partnerships with national labs to support needs once samples are collected; site-specific recommendations on workflow, standard operating procedures, and protocols; and a support team for current medical staff, among other services.  

For more, click here. 

 


Related to this article

© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.